Cansino Biologics, Inc. Class ASSE: 688185

Announcement on Convening the Q3 2024 Performance Briefing

· Issued by Cansino Biologics, Inc. Class A via Shanghai Stock Exchange
Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment